Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003119839 | SCV003795099 | pathogenic | Cohen syndrome | 2022-07-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the VPS13B protein in which other variant(s) (deletion of exons 18-19) have been determined to be pathogenic (PMID: 19533689). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 6-21 of the VPS13B gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. |